Gaps in ambulatory patient safety for immunosuppressive specialty medications.

Patterson S, Schmajuk G, Evans M, et al. Jt Comm J Qual Patient Saf. 2019;45:348-367.

This retrospective cohort study sought to determine whether screening for tuberculosis and hepatitis B and C was consistently performed prior to initiating immunosuppressive medications. About a quarter of patients were appropriately screened for all three infections before starting these high-risk medications, demonstrating the need for safety protocols regarding provision of immunosuppressive medication.

PubMed citation Available at